Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Corporate Reputation of Pharma Companies 2016-2017: Perspective of 63 HIV/AIDS Patient Groups - Research and Markets

Research and Markets
Posted on: 14 Aug 17

The "The Corporate Reputation of Pharma Companies, 2016: from the Perspective of 63 HIV/AIDS Patient Groups" report has been added to Research and Markets' offering.

The HIV/AIDS results are drawn from the opinions of 63 patient groups specialising in HIV/AIDS, based in 35 countries, and, in turn, are derived from the global review of pharma's corporate reputation (conducted November 2016 to early-February 2017).

8 pharma companies are included in this 2016 HIV/AIDS therapy-area 'extra' analysis:

  • AbbVie
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Gilead
  • Janssen
  • Merck & Co
  • Roche
  • ViiV Healthcare

How pharma is assessed for corporate reputation

Industry-wide questions:

  • How the pharma industry's corporate reputation compares with that of other healthcare industries.
  • How the pharma industry's corporate reputation has changed over the past five years.
  • How good or bad the pharma industry is at various activities of relevance to patients and patient groups.

7 indicators for the corporate reputation of individual pharma companies:

  1. Patient centricity.
  2. Information for patients.
  3. Patient safety.
  4. Usefulness of products.
  5. Transparency.
  6. Integrity.
  7. Patient-group relationships(new for 2016).

INDUSTRY-WIDE FINDINGS

  • In 2016, HIV/AIDS patient groups show higher regard for pharma than patient groups from most other therapy areas. 44% of HIV/AIDS patient groups thought that the pharma industry had an "Excellent" or "Good" corporate reputation in 2016 (just 38% of patient groups across all therapy areas thought the same).
  • HIV/AIDS patient groups ranked the generics drug industry as 1st among 8 healthcare-industry sectors for having a "Excellent" or "Good" corporate reputation in 2016. They ranked multinational pharma 4th.
  • HIV/AIDS patient groups were, on the whole, positive about many of the pharma industry's activities in 2016. Up to 76% stated that pharma was "Excellent" or "Good" at producing high-quality products of use to patients [see chart].
  • However, only 21% of HIV/AIDS patient groups stated that pharma was "Excellent" or "Good" at integrity (the figure among patient groups across all therapy areas was 35%, and 55% among haemophilia patient groups).

THE PARTNERSHIPS BETWEEN PHARMA COMPANIES AND PATIENT GROUPS

  • 63 HIV/AIDS patient groups participated in the 2016 study. They came from Africa, Asia, Europe, North America, and Central & Latin America. The majority of the HIV/AIDS patient groups worked with at least two-to-four pharma companies (and many worked with more than that). As the chart above shows, one HIV/AIDS patient group worked with as many as 12 pharma companies. Half of the 63 HIV/AIDS patient groups worked with four-to-seven pharma companies.
  • The company with which HIV/AIDS patient groups were most familiar was Gilead (83% of respondent HIV/AIDS patient groups were familiar with the company).

INDIVIDUAL COMPANY FINDINGS

  • ViiV Healthcare ranked overall 1st in 2016 for corporate reputation among the 8 pharma companies, when judged by HIV/AIDS patient groups.
  • ViiV Healthcare also ranked 1st for six of the seven indicators of corporate reputation. The exception was the provision of high-quality products, for which HIV/AIDS patient groups ranked Gilead 1st.

For more information about this report visit https://www.researchandmarkets.com/research/r3x24h/the_corporate

View source version on businesswire.com: http://www.businesswire.com/news/home/20170814005582/en/

Business Wire
www.businesswire.com

Last updated on: 14/08/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.